Investors
Other IR Information
Investors
Other IR Information
Fiscal Year Ended 2025/3
-
2025-05-20Transcript including Q&As of the Results Briefing for the Fiscal Year Ended March 31, 2025
-
2025-02-13Notice Concerning Commencement of New Business
-
2025-02-13Notice Concerning Revision of Forecast of Financial Results
-
2024-11-21Transcript including Q&As of the Results Briefing for the second quarter ended September 30, 2024
Fiscal Year Ended 2024/3
-
2023-11-24Transcript including Q&As of the Results Briefing for the second quarter ended September 30, 2023
-
2023-11-13Notice of Revision of Forecast of Financial Results (Upward Revision)
-
2023-11-13Notice of Additional Investment in Cambrian, Inc.
Fiscal Year Ended 2023/3
-
2023-03-10Notice of Changes in Representative Directors’ Positions, Organization and Personnel
-
2022-11-21Transcript including Q&As of the Results Briefing for the second quarter ended September 30, 2022
-
2022-4-13Notice of Additional Order of RS1
Fiscal Year Ended 2022/3
-
2022-02-10Notice of Large-scale Order
-
2021-11-10Notice of Revision of Forecast of Financial Results
-
2021-10-12Business Plan and Growth Potential
-
2021-10-12Notice of Application for Selection of New Market Segment “Growth Market”
-
2021-09-03Presentation for IR Seminar for Personal Investors on August 28, 2021
-
2021-08-11Notice of Large-scale Order
-
2021-05-14Notice of Medium-term Business Plan
-
2021-04-09Notice of Capital and Business Alliance with Cambrian, Inc.
-
2021-04-09Notice of Medium-term Business Direction
Fiscal Year Ended 2021/3
-
2021-04-09Notice of Revision of Forecast of Financial Results
-
2020-05-12Notice of changes in representative director and directors and personnel change
-
2020-05-12Notice of Introduction of Restricted Stock Compensation System
-
2020-05-12Notice of partial amendment to the Articles of Incorporation
-
2020-04-10Notice of Revision of Forecast of Financial Results
